FRI-183-A phase 3 study comparing switching from tenofovir disoproxil fumarate to tenofovir alafenamide with continued TDF treatment in virologically-suppressed patients with chronic hepatitis B (CHB): week 48 efficacy and safety results
Journal article published in 2019 by
This paper was not found in any repository, but could be made available legally by the author.
Preprint: archiving allowed
Data provided by